BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Want to see BBOT full AI Analyst Report?
Technical Sentiment
Overall Consensus
Neutral
9Bullish
2Neutral
11Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting BridgeBio Oncology Therapeutics is a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 9.10, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 9.70, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
8.67
8.87
9.04
9.24
9.41
9.61
9.78
Fibonacci
8.87
9.01
9.10
9.24
9.38
9.47
9.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
9.22Buy
9.19Buy
MA10
8.93Buy
9.07Buy
MA20
8.92Buy
9.10Buy
MA50
9.67Sell
9.70Sell
MA100
10.93Sell
10.37Sell
MA200
10.97Sell
10.59Sell
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 9.07, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 10.37, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 9.67, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 10.93, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 10.97, creating a Sell signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
51.95
Neutral
STOCH (9,6)
83.91
Sell
STOCHRSI (14)
83.91
Sell
MACD (12,26)
-0.14
Sell
ADX (14)
16.63
Buy
Williams %R
-19.01
Sell
CCI (14)
162.98
Sell
ATR (14)
0.59
-
Ultimate Oscillator
52.86
Neutral
ROC
5.29
Buy
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 51.95, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 16.63, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is 162.98, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is 5.29, creating a Buy signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Hold.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 51.95, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is -0.14, which suggests BBOT is a Sell.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 9.22, which suggests BBOT is a Buy.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 8.92, which suggests BBOT is a Buy.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 9.67, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 10.97, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -19.01, which suggests BBOT is a Sell.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is 162.98, which suggests BBOT is a Sell.